Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01)

This grant encourages applications of original research addressing barriers that limit progress toward effective open- and closed-loop glucose control systems. Proposed research should tackle important obstacles at the level of sensing, hormone formulation and delivery, self-management decision support systems, and/or design of automated controllers/algorithms able to manage an integrated platform.

Funding: $500,000 per year

Duration: 4 years

Research Authority due date:27.2.20

LOI (encouraged) due ate: 7.3.20

Full proposal due date: 7.4.20